Anatomical factors and device integration require modified diagnostic workflows to manage complicated urinary tract ...

Fresh with a rebrand, Cyllene will advance gene therapies built on a platform that uses a modified form of the herpes virus for delivery.

Financing co-led by GordonMD Global Investments® LP and M VenturesCompany rebrands from EG 427 to Cyllene Therapeutics Paris, July 07, 2026 ...

Cyllene Therapeutics ("Cyllene"), formerly known as EG 427, today announced the closing of a €33 million Series C financing round co-led by GordonMD Global Investments® LP ("GordonMD") and Merck ...

Cyllene Therapeutics ("Cyllene"), formerly known as EG 427, today announced the closing of a ?33 million Series C financing round co-led by GordonMD Global Investments® LP ("GordonMD") and Merck ...

Joe DiMaggio Children's Hospital made history with its first remote living donor kidney transplant, giving 18-year-old ...

Vertex Pharmaceuticals Incorporated will report its second quarter 2026 financial results on Monday, August 3, 2026, after the financial markets close. The company will host a conference call and ...

Women with bladder cancer face differences in diagnosis and treatment and have worse outcomes than men despite lower incidence. This disparity cannot be univocally ascribed to bias or biology but ...

Today, a brief rundown of news involving Prime Medicine and Saol Therapeutics, as well as updates from Revolution Medicines and Cyllene Therapeutics that you may have missed. According to a new ...